Regenerative Medical Technology Group Inc.: basic earnings per share
Basic earnings per share for Regenerative Medical Technology Group Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Regenerative Medical Technology Group Inc. financial histories
What this measure means
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
Exact concept: us-gaap:EarningsPerShareBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2018-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -0.62 | USD/shares | 2026-05-14 | 10-K · 0001213900-26-056841 |
| 2024-01-01 | 2024-12-31 | -0.44 | USD/shares | 2026-05-14 | 10-K · 0001213900-26-056841 |
| 2023-01-01 | 2023-12-31 | -0.79 | USD/shares | 2025-04-15 | 10-K · 0001213900-25-032016 |
| 2022-01-01 | 2022-12-31 | -0.45 | USD/shares | 2024-04-15 | 10-K · 0001213900-24-032991 |
| 2021-01-01 | 2021-12-31 | -1.12 | USD/shares | 2023-04-14 | 10-K · 0001213900-23-029942 |
| 2020-01-01 | 2020-12-31 | -0.63 | USD/shares | 2022-05-05 | 10-K · 0001213900-22-024049 |
| 2019-01-01 | 2019-12-31 | -0.47 | USD/shares | 2020-12-09 | 10-K · 0001213900-20-041866 |
| 2018-01-01 | 2018-12-31 | -0.5 | USD/shares | 2020-12-09 | 10-K · 0001213900-20-041866 |
Related financial histories
- Regenerative Medical Technology Group Inc.: total assets
- Regenerative Medical Technology Group Inc.: total liabilities
- Regenerative Medical Technology Group Inc.: stockholders equity
- Regenerative Medical Technology Group Inc.: cash and cash equivalents
- Regenerative Medical Technology Group Inc.: net income or loss
- Regenerative Medical Technology Group Inc.: operating cash flow
- Regenerative Medical Technology Group Inc.: capital expenditure payments
- Regenerative Medical Technology Group Inc.: revenue
- Regenerative Medical Technology Group Inc.: financing cash flow
- Regenerative Medical Technology Group Inc.: investing cash flow
- Regenerative Medical Technology Group Inc.: retained earnings or deficit
- Regenerative Medical Technology Group Inc.: basic weighted-average shares
- Regenerative Medical Technology Group Inc.: diluted weighted-average shares
- Regenerative Medical Technology Group Inc.: diluted earnings per share
- Regenerative Medical Technology Group Inc.: income tax expense or benefit
- Regenerative Medical Technology Group Inc.: net property, plant and equipment
- Regenerative Medical Technology Group Inc.: operating income or loss
- Regenerative Medical Technology Group Inc.: current assets
- Regenerative Medical Technology Group Inc.: interest expense
- Regenerative Medical Technology Group Inc.: current liabilities
- Regenerative Medical Technology Group Inc.: current accounts payable
- Regenerative Medical Technology Group Inc.: goodwill carrying amount
- Regenerative Medical Technology Group Inc.: operating expenses
- Regenerative Medical Technology Group Inc.: gross profit
- Regenerative Medical Technology Group Inc.: cost of revenue
Inspect the source
- Entity
- Regenerative Medical Technology Group Inc. / CIK 0001760026
- Captured
- 2026-09-21T17:29:44.976Z
- SEC response SHA-256
3f18c270ccc08f9d5bf86e3ef67179bbe60a93f4f0183aa6c8696fc204b08c29
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001760026.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))